Application of a Tumor Suppressor (C-CAMl)-expressing Recombinant Adenovirus in Androgen-independent Human Prostate Cancer Therapy: A Preclinical Study

D. I. Kleinerman, W. W. Zhang, S. H. Lin, N. T. Van Andrew, A. C. Von Eschenbach, J. T. Hsieh